Dose-painting Radiation for LA-NSCLC

NARecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung Cancer Stage IIINon-small Cell Lung Cancer Stage II
Interventions
RADIATION

Dose-Painting Radiation

"Radiation therapy:~1. Delineation of target area:~ The primary tumor is delineated into different target areas according to the anatomical position of the tumor, including the central area tumor GTV-Tcentral and GTV-Tperipheral.~2. Exposure dose:~1\) GTV-Tcentral: 2.0~2.5Gy/f, bid, 10-13d, physical dose 40-65Gy 2) GTV-Tperipheral: 3.0~4.0Gy/f, bid, 10-13d, physical dose 60-104Gy 3) GTV-N (mediastinal lymph node): 2.0Gy/f, bid, 10-13d, physical dose 40-52Gy"

Trial Locations (4)

610041

RECRUITING

Sichuan Cancer Hospital & Institute, Chengdu

Unknown

RECRUITING

Yunnan Cancer Hospital, Kunming

RECRUITING

Chongqing university three Gorges hospital, Wanzhou

RECRUITING

General Hospital of Ningxia Medical University, Yingchuan

All Listed Sponsors
lead

Sichuan Cancer Hospital and Research Institute

OTHER